Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Galmed Pharmaceuticals Ltd. buy Barclays PLC

Galmed Pharmaceuticals Ltd.
Start price
€6.40
10.11.25 / 50%
Target price
€98.63
10.11.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 10.11.26. The prediction end date can be changed by Barclays_PLC at any time.
Performance without dividends (%)
Name 1w
Galmed Pharmaceuticals Ltd. -
iShares Core DAX® 0.760%
iShares Nasdaq 100 0.732%
iShares Nikkei 225® 1.025%
iShares S&P 500 -0.036%

Comments by Barclays_PLC for this prediction

In the thread Galmed Pharmaceuticals Ltd. diskutieren
Prediction Buy
Perf. (%) -
Target price 98.633
Change
Ends at 10.11.26

Globus Medical (NYSE:GMED) had its price target raised by analysts at Barclays PLC from $106.00 to $114.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat

Barclays PLC 
0
Report Share
10.11.25

Stopped prediction by Barclays_PLC for Galmed Pharmaceuticals Ltd.

buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€6.40
11.06.25
-
11.06.26
-
19.09.24

Barclays PLC 
11.06.25 50%
buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€6.40
24.02.25
€98.39
24.02.26
-
19.09.24

Barclays PLC 
24.02.25 50%
buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€0.27
08.08.24
€85.19
08.08.25
2270.37%
09.08.25

Barclays PLC 
08.08.24 50%
buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€0.40
09.05.24
€78.88
09.05.25
1516.16%
10.05.25

Barclays PLC 
09.05.24 50%